Pfizer sues Johnson & Johnson over alleged biologics monopolization
Pfizer has sued Johnson & Johnson, accusing the company of using its clout with insurers to maintain a dominant position for its drug Remicade, a biologic used to treat arthritis and...To view the full article, register now.
Already a subscriber? Click here to view full article